NeuroSense Therapeutics Ltd. Warrant

NRSNW

...

NRSNW: NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases, these diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

Show NRSNW Financials

All

Government

Consumer Interest

SEC Filings

ESG/Other

Congress Trading

Recent trades of NRSNW by members of U.S. Congress

No Congress Trading data for this ticker

Congress Trading Dashboard

Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by NRSNW's directors and management

No recent Insider Trading for this ticker

Insider Trading Dashboard

Corporate Lobbying

Government lobbying spending instances

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

U.S. Patents

New patents grants

No new patents for this ticker

U.S. Patents Dashboard

Government Contracts

Federal grants, loans, and purchases

No Government Contracts for this ticker

Government Contracts Dashboard

Twitter

Followers on NRSNW's company Twitter account

WallStreetBets

Number of mentions of NRSNW in WallStreetBets Daily Discussion

NRSNW News

Recent insights relating to NRSNW

CNBC Recommendations

Recent picks made for NRSNW stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in NRSNW

Corporate Flights

Flights by private jets registered to NRSNW